INSULIN GLARGINE-YFGN

INSULIN GLARGINE-YFGN was reported 22376 times

INSULIN GLARGINE-YFGN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PULMONARY VASCULITIS 193 0.3587
1 TOTAL LUNG CAPACITY ABNORMAL 110 0.2828
2 CONJOINED TWINS 24 0.2424
3 CAPILLARITIS 64 0.2319
4 THERAPEUTIC DRUG MONITORING ANALYSIS INCORRECTLY PERFORMED 22 0.2316
5 URETERIC COMPRESSION 15 0.1974
6 SPIROMETRY ABNORMAL 106 0.1773
7 MITE ALLERGY 110 0.1679
8 HUMAN RHINOVIRUS TEST POSITIVE 62 0.1662
9 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 96 0.1310
10 MYCOTIC ALLERGY 110 0.1287
11 VIRAL TEST POSITIVE 45 0.1240
12 NEURITIS 190 0.1230
13 DUST ALLERGY 110 0.1121
14 DIABETIC METABOLIC DECOMPENSATION 147 0.1058
15 THERAPEUTIC DRUG MONITORING ANALYSIS NOT PERFORMED 31 0.1051
16 PNEUMONIA HAEMOPHILUS 50 0.1029
17 ANTI-INSULIN ANTIBODY POSITIVE 19 0.0909
18 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 61 0.0868
19 CARDIOSPASM 44 0.0789
20 HYPOGLYCAEMIC ENCEPHALOPATHY 30 0.0771
21 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 157 0.0769
22 CONJUNCTIVITIS ALLERGIC 111 0.0749
23 IMMUNISATION 29 0.0668
24 RESPIRATORY SYMPTOM 187 0.0657
25 INSULIN AUTOIMMUNE SYNDROME 22 0.0616
26 PALMOPLANTAR KERATODERMA 43 0.0593
27 SYSTEMIC INFECTION 96 0.0579
28 INJECTION SITE HYPERTROPHY 17 0.0521
29 HYPOGLYCAEMIC COMA 137 0.0475
30 PRODUCT MONITORING ERROR 61 0.0422
31 HYPOGLYCAEMIA UNAWARENESS 15 0.0419
32 FORCED EXPIRATORY VOLUME DECREASED 117 0.0413
33 NORMOCHROMIC NORMOCYTIC ANAEMIA 119 0.0396
34 DIABETIC KETOSIS 15 0.0395
35 PULMONARY ALVEOLAR HAEMORRHAGE 202 0.0360
36 HYPOGLYCAEMIA 1741 0.0359
37 NEUROLOGICAL SYMPTOM 197 0.0344
38 TRICHOGLOSSIA 14 0.0341
39 CRYSTAL NEPHROPATHY 20 0.0338
40 DIABETES MELLITUS INADEQUATE CONTROL 539 0.0304
41 EUGLYCAEMIC DIABETIC KETOACIDOSIS 116 0.0281
42 DIABETIC FOOT 84 0.0274
43 HYPERGLYCAEMIA 952 0.0261
44 BLOOD GLUCOSE FLUCTUATION 285 0.0260
45 KETONURIA 21 0.0258
46 KETOSIS 27 0.0249
47 TONGUE BITING 51 0.0247
48 DIABETIC RETINOPATHY 83 0.0244
49 COGWHEEL RIGIDITY 25 0.0238
50 ATRIAL TACHYCARDIA 50 0.0238
51 DEVICE MECHANICAL ISSUE 322 0.0235
52 MAST CELL ACTIVATION SYNDROME 32 0.0228
53 LIPOHYPERTROPHY 14 0.0225
54 ARTERIOSCLEROSIS CORONARY ARTERY 145 0.0219
55 DIABETIC KETOACIDOSIS 501 0.0208
56 VASCULITIS 240 0.0206
57 LEFT ATRIAL DILATATION 26 0.0204
58 DIABETIC NEPHROPATHY 44 0.0200
59 PRURITUS GENITAL 47 0.0199
60 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 22 0.0198
61 INSULIN RESISTANCE 40 0.0192
62 DIABETIC NEUROPATHY 94 0.0190
63 NON-CARDIOGENIC PULMONARY OEDEMA 20 0.0189
64 OBSTRUCTIVE AIRWAYS DISORDER 209 0.0188
65 GLYCOSYLATED HAEMOGLOBIN INCREASED 464 0.0184
66 GLOMERULAR FILTRATION RATE INCREASED 15 0.0182
67 TONGUE INJURY 17 0.0181
68 HYPOGLYCAEMIC UNCONSCIOUSNESS 35 0.0177
69 DIABETIC COMA 48 0.0171
70 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 20 0.0167
71 LACTIC ACIDOSIS 534 0.0165
72 CLOSTRIDIUM TEST POSITIVE 35 0.0159
73 HAEMATOMA MUSCLE 19 0.0158
74 ARTERIOSCLEROSIS 149 0.0158
75 PYELOCALIECTASIS 15 0.0157
76 DRUG CLEARANCE DECREASED 20 0.0153
77 FULL BLOOD COUNT ABNORMAL 160 0.0151
78 AUTONOMIC NEUROPATHY 14 0.0138
79 KETOACIDOSIS 103 0.0137
80 CRYPTOCOCCOSIS 22 0.0135
81 DIABETIC FOOT INFECTION 19 0.0134
82 GLYCOSURIA 18 0.0133
83 FOOT AMPUTATION 19 0.0130
84 MUCOSAL DRYNESS 26 0.0129
85 CAROTID ARTERY OCCLUSION 46 0.0126
86 BLOOD GLUCOSE ABNORMAL 232 0.0125
87 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 15 0.0125
88 HAEMATOCRIT INCREASED 27 0.0118
89 HYPOVOLAEMIA 68 0.0116
90 AMYLOIDOSIS 20 0.0116
91 PULMONARY FIBROSIS 214 0.0111
92 PERIODONTITIS 24 0.0111
93 MULTIPLE USE OF SINGLE-USE PRODUCT 62 0.0110
94 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 181 0.0106
95 PNEUMONIA STAPHYLOCOCCAL 21 0.0106
96 GINGIVAL HYPERTROPHY 16 0.0105
97 TENSION HEADACHE 45 0.0105
98 SLEEP TERROR 44 0.0104
99 URINE KETONE BODY PRESENT 16 0.0101
100 STEROID DIABETES 15 0.0100
101 MOUTH HAEMORRHAGE 73 0.0099
102 NEUROLOGICAL DECOMPENSATION 23 0.0099
103 BLOOD GLUCOSE DECREASED 477 0.0099
104 RETINOPATHY 36 0.0096
105 HYPERKALAEMIA 338 0.0096
106 NODULE 122 0.0093
107 DIABETIC COMPLICATION 23 0.0090
108 KLEBSIELLA INFECTION 44 0.0087
109 INTERNATIONAL NORMALISED RATIO FLUCTUATION 18 0.0087
110 BLOOD GLUCOSE INCREASED 1627 0.0086
111 STENOSIS 16 0.0085
112 GASTROINTESTINAL HYPOMOTILITY 19 0.0084
113 PULSELESS ELECTRICAL ACTIVITY 35 0.0084
114 HYPERLACTACIDAEMIA 22 0.0082
115 ELECTROLYTE IMBALANCE 95 0.0082
116 DISORGANISED SPEECH 15 0.0081
117 CHOREA 14 0.0081
118 HYPERSENSITIVITY VASCULITIS 21 0.0080
119 HAEMOPTYSIS 223 0.0080
120 HAEMOGLOBIN INCREASED 36 0.0079
121 INABILITY TO AFFORD MEDICATION 75 0.0075
122 EXTREMITY NECROSIS 13 0.0074
123 METABOLIC ACIDOSIS 234 0.0073
124 TOE AMPUTATION 37 0.0073
125 HYPOTHYROIDISM 232 0.0073
126 ELECTROCARDIOGRAM ABNORMAL 56 0.0071
127 ESSENTIAL HYPERTENSION 13 0.0071
128 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 29 0.0071
129 POLYDIPSIA 28 0.0071
130 OCULOGYRIC CRISIS 15 0.0070
131 GANGRENE 42 0.0070
132 ACUTE KIDNEY INJURY 1066 0.0070
133 RENAL TRANSPLANT 25 0.0069
134 METABOLIC ENCEPHALOPATHY 20 0.0067
135 UROSEPSIS 61 0.0066
136 PRODUCT STORAGE ISSUE 25 0.0066
137 POLYURIA 54 0.0066
138 TACHYPNOEA 89 0.0065
139 WRONG PRODUCT ADMINISTERED 44 0.0065
140 DEVICE OPERATIONAL ISSUE 28 0.0065
141 HYPOXIA 224 0.0064
142 ABSCESS LIMB 27 0.0063
143 PSEUDOMEMBRANOUS COLITIS 14 0.0063
144 POTENTIATING DRUG INTERACTION 21 0.0063
145 HYPOTHERMIA 63 0.0062
146 BLOOD CHLORIDE DECREASED 16 0.0062
147 PANCREATIC DISORDER 30 0.0061
148 HYPERVOLAEMIA 30 0.0061
149 HYPOVOLAEMIC SHOCK 29 0.0060
150 METHAEMOGLOBINAEMIA 14 0.0060
151 ENTEROCOCCAL INFECTION 29 0.0060
152 ACUTE RESPIRATORY FAILURE 115 0.0060
153 PANCREATIC CARCINOMA METASTATIC 17 0.0060
154 BLINDNESS TRANSIENT 44 0.0060
155 HEPATIC CYTOLYSIS 76 0.0060
156 ATRIOVENTRICULAR BLOCK SECOND DEGREE 18 0.0059
157 ACIDOSIS 45 0.0059
158 PHARYNGITIS 73 0.0059
159 ESCHERICHIA URINARY TRACT INFECTION 25 0.0059
160 LACUNAR INFARCTION 14 0.0058
161 LEG AMPUTATION 24 0.0058
162 IMPAIRED GASTRIC EMPTYING 79 0.0058
163 VITAMIN B12 DEFICIENCY 23 0.0057
164 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 14 0.0057
165 HYPERTRIGLYCERIDAEMIA 33 0.0056
166 SUBARACHNOID HAEMORRHAGE 57 0.0056
167 HAEMOLYTIC ANAEMIA 50 0.0056
168 PEMPHIGOID 42 0.0056
169 DERMATITIS EXFOLIATIVE GENERALISED 19 0.0055
170 IMMUNE-MEDIATED MYOSITIS 15 0.0054
171 RENAL TUBULAR NECROSIS 53 0.0054
172 OLIGOHYDRAMNIOS 18 0.0054
173 FACIAL PAIN 48 0.0054
174 PSYCHOMOTOR SKILLS IMPAIRED 14 0.0053
175 DYSLIPIDAEMIA 27 0.0053
176 EYE OEDEMA 13 0.0053
177 VASCULAR GRAFT 15 0.0052
178 NEPHROGENIC ANAEMIA 24 0.0052
179 ESCHERICHIA SEPSIS 15 0.0052
180 CARDIOPULMONARY FAILURE 20 0.0051
181 GLOMERULAR FILTRATION RATE DECREASED 63 0.0051
182 NECROTISING FASCIITIS 18 0.0051
183 RED CELL DISTRIBUTION WIDTH INCREASED 21 0.0050
184 CREPITATIONS 15 0.0050
185 LEUKOCYTOSIS 91 0.0050
186 LUNG CONSOLIDATION 14 0.0050
187 TYPE 1 DIABETES MELLITUS 30 0.0050
188 BLINDNESS 202 0.0050
189 WOUND COMPLICATION 17 0.0049
190 CARDIOTOXICITY 44 0.0049
191 LUNG DISORDER 241 0.0049
192 BLOOD CREATININE ABNORMAL 17 0.0049
193 LEFT VENTRICULAR HYPERTROPHY 21 0.0049
194 RENAL IMPAIRMENT 411 0.0049
195 PYELONEPHRITIS 42 0.0048
196 MYOCLONUS 57 0.0048
197 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 42 0.0047
198 VENTRICULAR TACHYCARDIA 77 0.0047
199 ACUTE MYOCARDIAL INFARCTION 137 0.0046
200 MYOPATHY 40 0.0046
201 HEPATIC NEOPLASM 15 0.0046
202 OLIGURIA 28 0.0045
203 ENTEROCOLITIS 26 0.0045
204 SINUS BRADYCARDIA 43 0.0044
205 SUPRAVENTRICULAR EXTRASYSTOLES 15 0.0044
206 PERIPHERAL ISCHAEMIA 18 0.0044
207 DISABILITY 87 0.0044
208 GAIT INABILITY 147 0.0044
209 NEUTROPHILIA 25 0.0044
210 UNRESPONSIVE TO STIMULI 113 0.0044
211 THROMBOCYTOSIS 16 0.0044
212 CARDIAC FAILURE ACUTE 29 0.0043
213 TOXIC ENCEPHALOPATHY 22 0.0043
214 SEROTONIN SYNDROME 83 0.0043
215 ANURIA 37 0.0043
216 RHABDOMYOLYSIS 179 0.0043
217 RENAL FAILURE CHRONIC 33 0.0043
218 HYPOKALAEMIA 197 0.0043
219 COVID-19 PNEUMONIA 50 0.0042
220 PRODUCT DISPENSING ISSUE 18 0.0042
221 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 202 0.0042
222 BLOOD UREA INCREASED 70 0.0042
223 DRUG LEVEL INCREASED 69 0.0042
224 DIALYSIS 59 0.0042
225 MENTAL STATUS CHANGES 115 0.0041
226 EYE HAEMORRHAGE 55 0.0041
227 DEVICE DEFECTIVE 71 0.0041
228 EYE MOVEMENT DISORDER 28 0.0041
229 SHOCK 94 0.0041
230 RESPIRATORY ACIDOSIS 16 0.0041
231 DRUG INTERACTION 644 0.0041
232 SUSPECTED SUICIDE 19 0.0041
233 DEVICE DELIVERY SYSTEM ISSUE 111 0.0041
234 DECUBITUS ULCER 33 0.0040
235 TOOTHACHE 73 0.0040
236 BLOOD TRIGLYCERIDES INCREASED 71 0.0040
237 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 41 0.0040
238 CARDIAC FAILURE CHRONIC 17 0.0040
239 ISCHAEMIC STROKE 71 0.0040
240 NEPHROPATHY 37 0.0040
241 CLOSTRIDIUM DIFFICILE COLITIS 42 0.0040
242 ENCEPHALOPATHY 97 0.0039
243 HYPONATRAEMIA 220 0.0039
244 HYPERURICAEMIA 16 0.0039
245 CHOLECYSTITIS ACUTE 22 0.0039
246 ATRIOVENTRICULAR BLOCK 30 0.0039
247 BLOOD POTASSIUM INCREASED 63 0.0039
248 BACTERAEMIA 46 0.0039
249 CUTANEOUS VASCULITIS 14 0.0038
250 ASPERGILLUS INFECTION 25 0.0038
251 RETINAL DETACHMENT 35 0.0038
252 PNEUMONIA FUNGAL 15 0.0038
253 ASPHYXIA 31 0.0038
254 AMYLASE INCREASED 14 0.0038
255 LOWER GASTROINTESTINAL HAEMORRHAGE 28 0.0038
256 CHOLECYSTITIS 45 0.0038
257 GENERAL PHYSICAL HEALTH DETERIORATION 437 0.0038
258 BUNDLE BRANCH BLOCK LEFT 16 0.0038
259 SUBCUTANEOUS ABSCESS 18 0.0038
260 PRODUCT DOSE OMISSION 245 0.0037
261 BRADYCARDIA 199 0.0037
262 CREATININE RENAL CLEARANCE DECREASED 15 0.0037
263 CYTOKINE RELEASE SYNDROME 75 0.0037
264 DRUG-INDUCED LIVER INJURY 117 0.0037
265 END STAGE RENAL DISEASE 68 0.0037
266 WHEEZING 220 0.0037
267 CHOLANGITIS 23 0.0037
268 PRODUCTIVE COUGH 177 0.0037
269 CATARACT OPERATION 22 0.0037
270 SHOCK HAEMORRHAGIC 30 0.0037
271 CATARACT 219 0.0037
272 HYPOPHAGIA 94 0.0037
273 SPINAL STENOSIS 15 0.0036
274 RESPIRATORY FAILURE 264 0.0036
275 RALES 21 0.0036
276 METABOLIC DISORDER 21 0.0036
277 BLOOD CREATINE INCREASED 16 0.0036
278 DEHYDRATION 482 0.0036
279 BLOOD LACTIC ACID INCREASED 19 0.0036
280 CARDIAC OPERATION 31 0.0036
281 CONGESTIVE CARDIOMYOPATHY 15 0.0036
282 DERMATITIS EXFOLIATIVE 18 0.0036
283 STENT PLACEMENT 29 0.0036
284 SKIN ULCER 92 0.0036
285 ALTERED STATE OF CONSCIOUSNESS 77 0.0036
286 HYPOMAGNESAEMIA 49 0.0035
287 HYPERTENSIVE CRISIS 39 0.0035
288 CACHEXIA 18 0.0035
289 MULTIPLE ORGAN DYSFUNCTION SYNDROME 99 0.0035
290 LOCALISED INFECTION 84 0.0035
291 HAEMORRHAGIC STROKE 27 0.0035
292 SUPRAVENTRICULAR TACHYCARDIA 33 0.0034
293 HEPATIC STEATOSIS 64 0.0034
294 DIVERTICULUM INTESTINAL 15 0.0034
295 OSTEOMYELITIS 62 0.0034
296 GENERALISED OEDEMA 42 0.0034
297 PERICARDITIS 57 0.0034
298 ATRIAL FLUTTER 27 0.0034
299 PANCREATITIS ACUTE 76 0.0034
300 HYDRONEPHROSIS 25 0.0033
301 CORONARY ARTERY DISEASE 101 0.0033
302 BLINDNESS UNILATERAL 47 0.0033
303 HEPATIC ENCEPHALOPATHY 31 0.0033
304 BLOOD CREATININE INCREASED 216 0.0033
305 INTESTINAL ISCHAEMIA 18 0.0033
306 PRODUCT ADMINISTRATION ERROR 66 0.0033
307 HYPOPHOSPHATAEMIA 24 0.0032
308 ANOSMIA 47 0.0032
309 HEMIPLEGIA 27 0.0032
310 SEPTIC SHOCK 141 0.0032
311 ANAPHYLACTIC REACTION 179 0.0032
312 ANAL INCONTINENCE 29 0.0032
313 MONOPLEGIA 14 0.0032
314 SERUM FERRITIN INCREASED 17 0.0032
315 GASTRITIS EROSIVE 15 0.0032
316 HAEMODIALYSIS 27 0.0032
317 TUBULOINTERSTITIAL NEPHRITIS 60 0.0032
318 SALIVARY HYPERSECRETION 32 0.0032
319 ARTERIAL OCCLUSIVE DISEASE 25 0.0032
320 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 226 0.0032
321 RIGHT VENTRICULAR FAILURE 22 0.0031
322 ILEUS PARALYTIC 14 0.0031
323 LEFT VENTRICULAR DYSFUNCTION 21 0.0031
324 ADRENAL INSUFFICIENCY 38 0.0031
325 NEUROLEPTIC MALIGNANT SYNDROME 37 0.0031
326 BLOOD URIC ACID INCREASED 18 0.0031
327 URINARY TRACT DISORDER 14 0.0031
328 PRODUCT PRESCRIBING ERROR 74 0.0031
329 ANGINA PECTORIS 89 0.0031
330 CARDIOGENIC SHOCK 44 0.0031
331 GLAUCOMA 59 0.0031
332 DEPRESSED LEVEL OF CONSCIOUSNESS 121 0.0031
333 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 18 0.0030
334 NEUTROPHIL COUNT INCREASED 31 0.0030
335 EOSINOPHILIA 53 0.0030
336 RENAL FAILURE 401 0.0030
337 HYPERNATRAEMIA 15 0.0030
338 RENAL DISORDER 140 0.0030
339 ATRIOVENTRICULAR BLOCK COMPLETE 20 0.0030
340 DEMENTIA 83 0.0030
341 HYPOTENSION 595 0.0030
342 FLUID OVERLOAD 43 0.0030
343 PULSE ABSENT 14 0.0029
344 CYANOSIS 46 0.0029
345 TREATMENT NONCOMPLIANCE 160 0.0029
346 ANGINA UNSTABLE 19 0.0029
347 SEPSIS 325 0.0029
348 VISUAL IMPAIRMENT 360 0.0029
349 VARICOSE VEIN 15 0.0029
350 MYOSITIS 26 0.0029
351 DIPLOPIA 75 0.0029
352 GASTROENTERITIS 42 0.0029
353 PHARYNGEAL SWELLING 28 0.0029
354 MALNUTRITION 32 0.0029
355 PSYCHIATRIC SYMPTOM 21 0.0028
356 PROTHROMBIN TIME PROLONGED 17 0.0028
357 LOW DENSITY LIPOPROTEIN INCREASED 22 0.0028
358 BREATH SOUNDS ABNORMAL 14 0.0028
359 CELLULITIS 143 0.0028
360 BRONCHOPULMONARY ASPERGILLOSIS 22 0.0028
361 STAPHYLOCOCCAL SEPSIS 14 0.0028
362 DUODENAL ULCER 20 0.0028
363 PNEUMONIA BACTERIAL 26 0.0028
364 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 27 0.0028
365 ATELECTASIS 27 0.0028
366 BRAIN INJURY 28 0.0028
367 PULMONARY OEDEMA 125 0.0028
368 HYPERLIPIDAEMIA 33 0.0028
369 HAEMODYNAMIC INSTABILITY 21 0.0028
370 PRESYNCOPE 67 0.0028
371 CEREBRAL INFARCTION 67 0.0027
372 BLOOD CALCIUM INCREASED 24 0.0027
373 TRANSIENT ISCHAEMIC ATTACK 92 0.0027
374 COLD SWEAT 48 0.0027
375 HYPERKERATOSIS 15 0.0027
376 CHOLESTASIS 52 0.0027
377 POST PROCEDURAL INFECTION 22 0.0027
378 FOETAL DEATH 14 0.0027
379 FACIAL PARALYSIS 23 0.0027
380 MACULAR OEDEMA 15 0.0027
381 DIABETES MELLITUS 204 0.0027
382 UPPER GASTROINTESTINAL HAEMORRHAGE 45 0.0027
383 RETINAL HAEMORRHAGE 19 0.0027
384 TACHYCARDIA 236 0.0027
385 ANAEMIA 506 0.0027
386 CHRONIC KIDNEY DISEASE 201 0.0026
387 ORTHOSTATIC HYPOTENSION 46 0.0026
388 SOPOR 35 0.0026
389 BLOOD CREATINE PHOSPHOKINASE INCREASED 76 0.0026
390 AGRANULOCYTOSIS 49 0.0026
391 OEDEMA PERIPHERAL 321 0.0026
392 PLEURAL EFFUSION 160 0.0026
393 BLOOD BILIRUBIN INCREASED 71 0.0026
394 HYPERTHYROIDISM 38 0.0026
395 HYPOTONIA 26 0.0026
396 IRON DEFICIENCY ANAEMIA 24 0.0026
397 SMALL INTESTINAL OBSTRUCTION 32 0.0026
398 ARRHYTHMIA 123 0.0026
399 CARDIAC FAILURE 208 0.0026
400 HYPERCHOLESTEROLAEMIA 25 0.0026
401 HYPOGAMMAGLOBULINAEMIA 17 0.0026
402 NEPHROPATHY TOXIC 29 0.0026
403 TOXIC SKIN ERUPTION 26 0.0026
404 ERYTHEMA MULTIFORME 24 0.0026
405 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 14 0.0026
406 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 13 0.0026
407 PSEUDOMONAS INFECTION 22 0.0026
408 HAEMATEMESIS 65 0.0026
409 MUSCLE TWITCHING 59 0.0026
410 ASPARTATE AMINOTRANSFERASE INCREASED 135 0.0025
411 ALANINE AMINOTRANSFERASE INCREASED 156 0.0025
412 WOUND 71 0.0025
413 HYPOACUSIS 109 0.0025
414 CEREBRAL ISCHAEMIA 13 0.0025
415 CONDITION AGGRAVATED 768 0.0025
416 BLOOD ALBUMIN DECREASED 20 0.0025
417 THIRST 45 0.0025
418 URINE OUTPUT DECREASED 22 0.0025
419 NECROSIS 14 0.0025
420 HYPERHIDROSIS 323 0.0025
421 TRANSPLANT REJECTION 20 0.0025
422 DERMATITIS BULLOUS 18 0.0025
423 LOSS OF CONSCIOUSNESS 318 0.0025
424 INTENTIONAL PRODUCT MISUSE 217 0.0025
425 CHOLELITHIASIS 81 0.0025
426 HAEMATURIA 84 0.0025
427 INTENTIONAL OVERDOSE 157 0.0024
428 EJECTION FRACTION DECREASED 38 0.0024
429 ATRIAL FIBRILLATION 238 0.0024
430 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 440 0.0024
431 BLOOD SODIUM DECREASED 46 0.0024
432 CARDIO-RESPIRATORY ARREST 102 0.0024
433 CONFUSIONAL STATE 393 0.0024
434 SARS-COV-2 TEST POSITIVE 32 0.0024
435 TOXICITY TO VARIOUS AGENTS 407 0.0024
436 PRODUCT STORAGE ERROR 210 0.0024
437 ACUTE RESPIRATORY DISTRESS SYNDROME 42 0.0024
438 MUSCLE ATROPHY 30 0.0024
439 THROMBOSIS 190 0.0024
440 PNEUMONIA ASPIRATION 59 0.0024
441 VITAMIN D DEFICIENCY 23 0.0024
442 INTERNATIONAL NORMALISED RATIO INCREASED 67 0.0023
443 ASCITES 69 0.0023
444 GAMMA-GLUTAMYLTRANSFERASE INCREASED 52 0.0023
445 HEPATIC CIRRHOSIS 44 0.0023
446 HEPATOMEGALY 23 0.0023
447 NEPHROTIC SYNDROME 16 0.0023
448 DELIRIUM 81 0.0023
449 JOINT EFFUSION 16 0.0023
450 ANGIOPATHY 13 0.0023
451 DYSURIA 85 0.0023
452 SYNCOPE 231 0.0023
453 CEREBROVASCULAR ACCIDENT 391 0.0023
454 JAUNDICE 62 0.0023
455 EATING DISORDER 49 0.0023
456 BLOOD ALKALINE PHOSPHATASE INCREASED 57 0.0023
457 RENAL FAILURE ACUTE 97 0.0023
458 ANGIOEDEMA 101 0.0023
459 ASPIRATION 25 0.0023
460 PULMONARY EMBOLISM 216 0.0023
461 COMA 108 0.0023
462 SUICIDE ATTEMPT 137 0.0023
463 CYTOMEGALOVIRUS INFECTION 37 0.0022
464 PANCREATIC CARCINOMA 64 0.0022
465 BEDRIDDEN 29 0.0022
466 GASTRITIS 58 0.0022
467 DRUG ERUPTION 39 0.0022
468 PULMONARY CONGESTION 29 0.0022
469 SCIATICA 35 0.0022
470 ASTHMA 248 0.0022
471 INFARCTION 15 0.0022
472 PELVIC FRACTURE 17 0.0022
473 PANCREATITIS 115 0.0022
474 GENERALISED TONIC-CLONIC SEIZURE 36 0.0022
475 TOXIC EPIDERMAL NECROLYSIS 33 0.0022
476 URINARY TRACT INFECTION 370 0.0022
477 UPPER RESPIRATORY TRACT INFECTION 100 0.0022
478 BLOOD LACTATE DEHYDROGENASE INCREASED 34 0.0021
479 REFUSAL OF TREATMENT BY PATIENT 14 0.0021
480 RESPIRATORY RATE INCREASED 19 0.0021
481 MELAENA 47 0.0021
482 LIMB DISCOMFORT 66 0.0021
483 HEMIPARESIS 36 0.0021
484 HAEMATOCRIT DECREASED 42 0.0021
485 HYPOCALCAEMIA 40 0.0021
486 POISONING DELIBERATE 20 0.0021
487 BLOOD PRESSURE SYSTOLIC INCREASED 41 0.0021
488 MYOCARDIAL INFARCTION 366 0.0021
489 DISORIENTATION 83 0.0021
490 LYMPHOCYTE COUNT DECREASED 37 0.0021
491 HUNGER 29 0.0021
492 COGNITIVE DISORDER 97 0.0021
493 MUSCULAR WEAKNESS 236 0.0021
494 DYSARTHRIA 78 0.0021
495 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 108 0.0021
496 FALL 688 0.0021
497 BLOOD THYROID STIMULATING HORMONE INCREASED 19 0.0021
498 HYPERTENSION 436 0.0021
499 HYPOALBUMINAEMIA 16 0.0021
500 SKIN LESION 56 0.0020
501 EYE DISORDER 67 0.0020
502 STATUS EPILEPTICUS 23 0.0020
503 CEREBRAL DISORDER 15 0.0020
504 HYPERBILIRUBINAEMIA 21 0.0020
505 URINARY INCONTINENCE 60 0.0020
506 DECREASED APPETITE 468 0.0020
507 OESOPHAGITIS 22 0.0020
508 ILEUS 25 0.0020
509 ABSCESS 32 0.0020
510 PROTEINURIA 38 0.0020
511 BLOOD DISORDER 16 0.0020
512 RASH MACULO-PAPULAR 44 0.0020
513 PRODUCT DISPENSING ERROR 43 0.0020
514 TROPONIN INCREASED 15 0.0020
515 PANCYTOPENIA 110 0.0020
516 LOWER RESPIRATORY TRACT INFECTION 89 0.0020
517 PARALYSIS 28 0.0020
518 DRUG INTOLERANCE 187 0.0019
519 TRANSAMINASES INCREASED 43 0.0019
520 CARDIAC FAILURE CONGESTIVE 155 0.0019
521 HEPATIC FAILURE 58 0.0019
522 WOUND INFECTION 21 0.0019
523 ABDOMINAL PAIN 446 0.0019
524 FEBRILE NEUTROPENIA 127 0.0019
525 PAIN IN EXTREMITY 564 0.0019
526 NERVOUSNESS 100 0.0019
527 CARDIAC ARREST 158 0.0019
528 PALLOR 52 0.0019
529 FRACTURE 36 0.0019
530 ECCHYMOSIS 13 0.0019
531 THROMBOCYTOPENIA 212 0.0019
532 CARDIAC DISORDER 177 0.0019
533 HAEMATOMA 49 0.0019
534 FAECES DISCOLOURED 41 0.0019
535 VENTRICULAR FIBRILLATION 21 0.0019
536 RENAL PAIN 20 0.0019
537 PERITONITIS BACTERIAL 19 0.0019
538 OBESITY 30 0.0019
539 PNEUMONIA 605 0.0019
540 HAEMATOCHEZIA 103 0.0019
541 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 48 0.0019
542 HYPOKINESIA 27 0.0019
543 PERICARDIAL EFFUSION 43 0.0019
544 PAIN OF SKIN 50 0.0019
545 BLOOD IRON DECREASED 22 0.0019
546 BRAIN NEOPLASM 17 0.0018
547 CONTRAINDICATED PRODUCT ADMINISTERED 56 0.0018
548 MACULAR DEGENERATION 22 0.0018
549 RESPIRATORY DISORDER 55 0.0018
550 MEDICATION ERROR 102 0.0018
551 DYSPNOEA EXERTIONAL 69 0.0018
552 SINUS TACHYCARDIA 26 0.0018
553 PERIPHERAL SWELLING 282 0.0018
554 LIPASE INCREASED 14 0.0018
555 NEUROTOXICITY 32 0.0018
556 PULMONARY HYPERTENSION 38 0.0018
557 VOMITING 856 0.0018
558 RESPIRATORY ARREST 50 0.0018
559 FLANK PAIN 17 0.0018
560 LETHARGY 104 0.0018
561 LIMB INJURY 49 0.0018
562 ASTHENIA 676 0.0018
563 SUDDEN DEATH 19 0.0018
564 DEVICE ISSUE 161 0.0018
565 PNEUMOCYSTIS JIROVECII PNEUMONIA 18 0.0018
566 OEDEMA 97 0.0018
567 GOUT 32 0.0018
568 INFUSION SITE ERYTHEMA 15 0.0018
569 CANDIDA INFECTION 30 0.0018
570 DYSPNOEA 1005 0.0018
571 GASTROINTESTINAL HAEMORRHAGE 148 0.0018
572 SKIN DISORDER 59 0.0018
573 WEIGHT DECREASED 493 0.0018
574 LOW BIRTH WEIGHT BABY 14 0.0018
575 NEUROPATHY PERIPHERAL 167 0.0018
576 CORONARY ARTERY OCCLUSION 24 0.0017
577 PULMONARY MASS 26 0.0017
578 HIP FRACTURE 56 0.0017
579 SENSORY LOSS 14 0.0017
580 VENTRICULAR EXTRASYSTOLES 18 0.0017
581 THERAPY PARTIAL RESPONDER 27 0.0017
582 RESTLESSNESS 63 0.0017
583 WHITE BLOOD CELL COUNT INCREASED 66 0.0017
584 BACTERIAL INFECTION 32 0.0017
585 SPLENOMEGALY 20 0.0017
586 CHEST PAIN 316 0.0017
587 CIRCULATORY COLLAPSE 29 0.0017
588 STAPHYLOCOCCAL INFECTION 56 0.0017
589 LYMPHOPENIA 24 0.0017
590 EYE PRURITUS 57 0.0017
591 CLOSTRIDIUM DIFFICILE INFECTION 37 0.0017
592 SPINAL DISORDER 16 0.0017
593 DEVICE RELATED INFECTION 26 0.0017
594 MEMORY IMPAIRMENT 232 0.0017
595 DISTURBANCE IN ATTENTION 91 0.0017
596 THYROID DISORDER 26 0.0017
597 EMBOLISM 14 0.0017
598 INTENTIONAL DOSE OMISSION 48 0.0017
599 HEART RATE IRREGULAR 38 0.0017
600 URINARY RETENTION 56 0.0017
601 LIVER FUNCTION TEST INCREASED 36 0.0017
602 C-REACTIVE PROTEIN INCREASED 61 0.0017
603 ATRIAL SEPTAL DEFECT 14 0.0017
604 RESPIRATORY DISTRESS 46 0.0017
605 COLITIS 63 0.0017
606 PYREXIA 575 0.0017
607 BLOOD PRESSURE ABNORMAL 33 0.0017
608 PULMONARY ARTERIAL HYPERTENSION 24 0.0017
609 BLOOD CHOLESTEROL INCREASED 77 0.0017
610 LIP SWELLING 55 0.0016
611 DIZZINESS POSTURAL 16 0.0016
612 ROAD TRAFFIC ACCIDENT 69 0.0016
613 APHONIA 23 0.0016
614 SEIZURE 190 0.0016
615 HEPATIC FUNCTION ABNORMAL 61 0.0016
616 WEIGHT FLUCTUATION 17 0.0016
617 SLEEP APNOEA SYNDROME 31 0.0016
618 INJECTION SITE INDURATION 21 0.0016
619 HYPERCALCAEMIA 20 0.0016
620 NEUTROPHIL COUNT DECREASED 66 0.0016
621 SLEEP DISORDER 114 0.0016
622 CARDIOVASCULAR DISORDER 41 0.0016
623 JOINT DISLOCATION 17 0.0016
624 BLOOD CALCIUM DECREASED 18 0.0016
625 MITRAL VALVE INCOMPETENCE 18 0.0016
626 APHASIA 48 0.0016
627 ACCIDENTAL OVERDOSE 58 0.0016
628 HEAD INJURY 50 0.0016
629 PNEUMONITIS 43 0.0016
630 WEIGHT INCREASED 353 0.0016
631 PREMATURE DELIVERY 25 0.0016
632 SLUGGISHNESS 16 0.0016
633 NOCTURIA 19 0.0016
634 MUSCULOSKELETAL PAIN 82 0.0016
635 NEURALGIA 38 0.0016
636 RIB FRACTURE 32 0.0016
637 FLUID RETENTION 79 0.0016
638 INTENTIONAL PRODUCT USE ISSUE 136 0.0016
639 HAEMOGLOBIN DECREASED 159 0.0015
640 HIATUS HERNIA 20 0.0015
641 AMNESIA 100 0.0015
642 PALPITATIONS 180 0.0015
643 ACUTE HEPATIC FAILURE 21 0.0015
644 PETECHIAE 16 0.0015
645 HEPATOTOXICITY 34 0.0015
646 INJURY ASSOCIATED WITH DEVICE 31 0.0015
647 COVID-19 267 0.0015
648 BLOOD PRESSURE DECREASED 101 0.0015
649 INCREASED APPETITE 29 0.0015
650 ABDOMINAL DISTENSION 157 0.0015
651 BREAST PAIN 16 0.0015
652 MYOCARDIAL ISCHAEMIA 17 0.0015
653 CHOLECYSTECTOMY 17 0.0015
654 TREMOR 247 0.0015
655 EMPHYSEMA 15 0.0015
656 MUSCULOSKELETAL CHEST PAIN 23 0.0015
657 HEPATITIS 38 0.0015
658 MATERNAL EXPOSURE DURING PREGNANCY 132 0.0015
659 FOETAL EXPOSURE DURING PREGNANCY 120 0.0015
660 BODY TEMPERATURE INCREASED 30 0.0015
661 DYSPHAGIA 139 0.0015
662 INTERVERTEBRAL DISC PROTRUSION 32 0.0015
663 CARDIOMEGALY 18 0.0015
664 DEAFNESS 38 0.0015
665 GASTROINTESTINAL INFECTION 13 0.0014
666 RECTAL HAEMORRHAGE 62 0.0014
667 INJECTION SITE DISCOLOURATION 18 0.0014
668 KIDNEY INFECTION 28 0.0014
669 GAIT DISTURBANCE 273 0.0014
670 DIARRHOEA 919 0.0014
671 MUSCLE RIGIDITY 17 0.0014
672 TINNITUS 65 0.0014
673 CYSTITIS 45 0.0014
674 ANXIETY 402 0.0014
675 POST PROCEDURAL COMPLICATION 27 0.0014
676 OXYGEN SATURATION DECREASED 79 0.0014
677 LOWER LIMB FRACTURE 27 0.0014
678 INTERSTITIAL LUNG DISEASE 68 0.0014
679 CONSTIPATION 306 0.0014
680 ROTATOR CUFF SYNDROME 18 0.0014
681 INTERNAL HAEMORRHAGE 16 0.0014
682 SUBDURAL HAEMATOMA 20 0.0014
683 TYPE 2 DIABETES MELLITUS 47 0.0014
684 HEART RATE DECREASED 49 0.0014
685 NEPHROLITHIASIS 64 0.0014
686 ABDOMINAL PAIN UPPER 287 0.0014
687 RESPIRATORY DEPRESSION 17 0.0014
688 HALLUCINATION, AUDITORY 22 0.0014
689 SOMNOLENCE 276 0.0014
690 GASTRIC ULCER 26 0.0014
691 POLLAKIURIA 57 0.0014
692 DIZZINESS 681 0.0014
693 RED BLOOD CELL COUNT DECREASED 39 0.0014
694 BLOOD POTASSIUM DECREASED 41 0.0014
695 LYMPHOMA 21 0.0014
696 UPPER LIMB FRACTURE 27 0.0014
697 SPEECH DISORDER 71 0.0014
698 RESPIRATORY TRACT INFECTION 35 0.0013
699 PAIN IN JAW 38 0.0013
700 CEREBRAL HAEMORRHAGE 48 0.0013
701 RASH PAPULAR 30 0.0013
702 POLYNEUROPATHY 16 0.0013
703 INTESTINAL PERFORATION 15 0.0013
704 DIVERTICULITIS 37 0.0013
705 SCRATCH 14 0.0013
706 MALAISE 581 0.0013
707 DRUG EXPOSURE DURING PREGNANCY 45 0.0013
708 OSTEOARTHRITIS 56 0.0013
709 ULCER 21 0.0013
710 LEUKOPENIA 66 0.0013
711 HEART RATE INCREASED 130 0.0013
712 BALANCE DISORDER 113 0.0013
713 GASTRIC HAEMORRHAGE 15 0.0013
714 COMPLETED SUICIDE 108 0.0013
715 DYSTONIA 25 0.0013
716 CHROMATURIA 29 0.0013
717 HAEMORRHOIDS 25 0.0013
718 ELECTROCARDIOGRAM QT PROLONGED 46 0.0013
719 DISCOMFORT 77 0.0013
720 COAGULOPATHY 21 0.0013
721 DEVICE BREAKAGE 51 0.0013
722 HYPOAESTHESIA 188 0.0013
723 BLOOD PRESSURE INCREASED 191 0.0012
724 DEVICE FAILURE 19 0.0012
725 BRONCHITIS 92 0.0012
726 UNEVALUABLE EVENT 94 0.0012
727 REBOUND EFFECT 14 0.0012
728 VISION BLURRED 170 0.0012
729 INFECTION 179 0.0012
730 BACK DISORDER 20 0.0012
731 ANKLE FRACTURE 19 0.0012
732 NAUSEA 971 0.0012
733 EXPOSURE DURING PREGNANCY 76 0.0012
734 HALLUCINATION 92 0.0012
735 NEOPLASM 14 0.0012
736 SKIN HAEMORRHAGE 18 0.0012
737 DISSEMINATED INTRAVASCULAR COAGULATION 17 0.0012
738 BONE DISORDER 22 0.0012
739 ERECTILE DYSFUNCTION 31 0.0012
740 COUGH 338 0.0012
741 LIVER FUNCTION TEST ABNORMAL 35 0.0012
742 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 28 0.0012
743 SPINAL PAIN 14 0.0012
744 PRODUCT PRESCRIBING ISSUE 26 0.0012
745 PLATELET COUNT DECREASED 127 0.0012
746 MOVEMENT DISORDER 38 0.0012
747 LIVER INJURY 29 0.0012
748 CHILLS 138 0.0012
749 LIVER DISORDER 52 0.0012
750 ACCIDENT 14 0.0012
751 AGITATION 86 0.0012
752 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 20 0.0012
753 PERIPHERAL COLDNESS 16 0.0012
754 PERITONITIS 24 0.0012
755 LUNG INFECTION 18 0.0012
756 MOBILITY DECREASED 83 0.0012
757 NEUTROPENIA 157 0.0012
758 FEELING COLD 32 0.0011
759 MENTAL DISORDER 50 0.0011
760 ABDOMINAL DISCOMFORT 192 0.0011
761 DEVICE USE ISSUE 20 0.0011
762 PRODUCT USE ISSUE 214 0.0011
763 ABNORMAL BEHAVIOUR 45 0.0011
764 IMPAIRED HEALING 37 0.0011
765 SKIN EXFOLIATION 95 0.0011
766 JOINT INJURY 24 0.0011
767 SENSORY DISTURBANCE 18 0.0011
768 POOR QUALITY SLEEP 24 0.0011
769 POISONING 14 0.0011
770 EXPIRED PRODUCT ADMINISTERED 37 0.0011
771 INFLUENZA 124 0.0011
772 VERTIGO 67 0.0011
773 GINGIVAL BLEEDING 15 0.0011
774 TENDONITIS 17 0.0011
775 DYSSTASIA 32 0.0011
776 BACK PAIN 254 0.0011
777 OFF LABEL USE 957 0.0011
778 OVERDOSE 235 0.0011
779 HOSPITALISATION 167 0.0011
780 FEEDING DISORDER 22 0.0011
781 VISUAL ACUITY REDUCED 36 0.0011
782 INJECTION SITE MASS 40 0.0011
783 METASTASES TO LIVER 19 0.0011
784 RETCHING 23 0.0011
785 CHOKING 21 0.0011
786 PLATELET COUNT INCREASED 14 0.0011
787 CARPAL TUNNEL SYNDROME 15 0.0011
788 BLISTER 60 0.0011
789 FATIGUE 828 0.0011
790 PREMATURE BABY 32 0.0011
791 INTESTINAL OBSTRUCTION 40 0.0011
792 GASTROINTESTINAL DISORDER 95 0.0011
793 SWOLLEN TONGUE 33 0.0011
794 GASTROOESOPHAGEAL REFLUX DISEASE 85 0.0011
795 FOOT FRACTURE 20 0.0011
796 FUNGAL INFECTION 35 0.0010
797 DRUG DISPENSING ERROR 16 0.0010
798 EPILEPSY 32 0.0010
799 MOUTH ULCERATION 22 0.0010
800 HEPATIC ENZYME INCREASED 71 0.0010
801 ERUCTATION 20 0.0010
802 BONE MARROW FAILURE 21 0.0010
803 MUCOSAL INFLAMMATION 27 0.0010
804 SEDATION 27 0.0010
805 NEEDLE ISSUE 30 0.0010
806 INCORRECT DOSE ADMINISTERED BY DEVICE 27 0.0010
807 NEOPLASM MALIGNANT 68 0.0010
808 CARDIOMYOPATHY 15 0.0010
809 MYALGIA 172 0.0010
810 RENAL INJURY 30 0.0010
811 FACE OEDEMA 17 0.0010
812 HAEMORRHAGE INTRACRANIAL 15 0.0010
813 SWELLING 93 0.0010
814 VIRAL INFECTION 33 0.0010
815 OSTEOPENIA 15 0.0010
816 DRUG RESISTANCE 25 0.0010
817 MYELODYSPLASTIC SYNDROME 14 0.0010
818 DELUSION 15 0.0010
819 DYSPEPSIA 95 0.0010
820 HAEMORRHAGE 100 0.0010
821 KNEE ARTHROPLASTY 20 0.0009
822 INFLAMMATION 49 0.0009
823 PNEUMOTHORAX 15 0.0009
824 DRUG EFFECT LESS THAN EXPECTED 14 0.0009
825 GASTROENTERITIS VIRAL 17 0.0009
826 COLON CANCER 14 0.0009
827 FEMUR FRACTURE 29 0.0009
828 SCAR 16 0.0009
829 THROAT TIGHTNESS 25 0.0009
830 ARTHRALGIA 383 0.0009
831 CONJUNCTIVITIS 17 0.0009
832 AMENORRHOEA 16 0.0009
833 DRY MOUTH 74 0.0009
834 DEPRESSED MOOD 48 0.0009
835 MENTAL IMPAIRMENT 22 0.0009
836 FEELING ABNORMAL 216 0.0009
837 DRUG ABUSE 75 0.0009
838 TOOTH DISORDER 20 0.0009
839 DEEP VEIN THROMBOSIS 58 0.0009
840 ARTHRITIS 70 0.0009
841 TASTE DISORDER 18 0.0009
842 SURGERY 52 0.0009
843 NECK PAIN 49 0.0009
844 PRODUCT QUALITY ISSUE 119 0.0009
845 LYMPHADENOPATHY 31 0.0009
846 MUSCULOSKELETAL DISCOMFORT 15 0.0009
847 EPISTAXIS 65 0.0009
848 FEAR 23 0.0009
849 STEVENS-JOHNSON SYNDROME 19 0.0009
850 RASH GENERALISED 22 0.0008
851 ABORTION SPONTANEOUS 34 0.0008
852 INCORRECT DOSE ADMINISTERED 193 0.0008
853 STOMATITIS 51 0.0008
854 GALLBLADDER DISORDER 15 0.0008
855 CHEST DISCOMFORT 86 0.0008
856 NIGHT SWEATS 27 0.0008
857 HYPERSOMNIA 24 0.0008
858 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 39 0.0008
859 BASAL CELL CARCINOMA 13 0.0008
860 HEADACHE 521 0.0008
861 HERNIA 16 0.0008
862 RESTLESS LEGS SYNDROME 15 0.0008
863 PAIN 504 0.0008
864 PRODUCT DOSE OMISSION IN ERROR 23 0.0008
865 MULTI-ORGAN FAILURE 14 0.0008
866 PRESCRIBED UNDERDOSE 16 0.0008
867 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 44 0.0008
868 AGEUSIA 20 0.0008
869 THERAPY NON-RESPONDER 36 0.0008
870 BLOOD URINE PRESENT 15 0.0008
871 ILLNESS 81 0.0008
872 PRURITUS GENERALISED 17 0.0008
873 INSOMNIA 209 0.0008
874 SKIN DISCOLOURATION 36 0.0008
875 FEELING HOT 48 0.0008
876 PRURITUS 298 0.0008
877 MIGRAINE 74 0.0008
878 RASH MACULAR 27 0.0008
879 MALIGNANT NEOPLASM PROGRESSION 78 0.0008
880 FLATULENCE 43 0.0008
881 DISEASE RECURRENCE 36 0.0008
882 RASH PRURITIC 41 0.0008
883 DEPRESSION 171 0.0008
884 DRY SKIN 100 0.0007
885 HERPES ZOSTER 42 0.0007
886 ORAL PAIN 16 0.0007
887 PSYCHOTIC DISORDER 21 0.0007
888 EYE PAIN 40 0.0007
889 BLOOD PRESSURE FLUCTUATION 17 0.0007
890 CONTUSION 68 0.0007
891 NERVOUS SYSTEM DISORDER 22 0.0007
892 FREQUENT BOWEL MOVEMENTS 19 0.0007
893 IMPAIRED WORK ABILITY 15 0.0007
894 DYSPHONIA 41 0.0007
895 DRUG INEFFECTIVE 923 0.0007
896 NASOPHARYNGITIS 129 0.0007
897 PLASMA CELL MYELOMA 27 0.0007
898 RASH ERYTHEMATOUS 33 0.0007
899 INJECTION SITE BRUISING 55 0.0007
900 PROCEDURAL PAIN 19 0.0007
901 WHITE BLOOD CELL COUNT DECREASED 74 0.0007
902 MUSCLE SPASMS 125 0.0007
903 RASH 296 0.0007
904 ABDOMINAL PAIN LOWER 17 0.0007
905 EYE SWELLING 25 0.0007
906 DEVICE LEAKAGE 29 0.0007
907 RHINORRHOEA 43 0.0007
908 DYSKINESIA 27 0.0007
909 THERAPY CESSATION 34 0.0007
910 NEOPLASM PROGRESSION 23 0.0007
911 PARAESTHESIA 103 0.0007
912 BONE PAIN 38 0.0006
913 OROPHARYNGEAL PAIN 60 0.0006
914 EXTRA DOSE ADMINISTERED 26 0.0006
915 DEVICE MALFUNCTION 45 0.0006
916 INFUSION RELATED REACTION 42 0.0006
917 ANAPHYLACTIC SHOCK 16 0.0006
918 PRODUCT USE IN UNAPPROVED INDICATION 153 0.0006
919 BURNING SENSATION 43 0.0006
920 JOINT STIFFNESS 16 0.0006
921 ILL-DEFINED DISORDER 37 0.0006
922 HYPERSENSITIVITY 113 0.0006
923 OSTEOPOROSIS 25 0.0006
924 URTICARIA 101 0.0006
925 UNDERDOSE 43 0.0006
926 INJECTION SITE RASH 18 0.0006
927 MOOD ALTERED 16 0.0006
928 LUNG NEOPLASM MALIGNANT 24 0.0006
929 SWELLING FACE 38 0.0006
930 PRODUCT DOSE OMISSION ISSUE 171 0.0006
931 FIBROMYALGIA 14 0.0006
932 JOINT SWELLING 69 0.0006
933 OSTEONECROSIS OF JAW 14 0.0006
934 IRRITABILITY 34 0.0006
935 EAR INFECTION 15 0.0006
936 LACRIMATION INCREASED 17 0.0006
937 AGGRESSION 28 0.0006
938 ALOPECIA 109 0.0006
939 INJECTION SITE HAEMORRHAGE 44 0.0006
940 DISEASE PROGRESSION 64 0.0005
941 ANHEDONIA 14 0.0005
942 DEATH 457 0.0005
943 GASTRIC DISORDER 18 0.0005
944 WITHDRAWAL SYNDROME 22 0.0005
945 ERYTHEMA 107 0.0005
946 INJECTION SITE PAIN 157 0.0005
947 INJECTION SITE PRURITUS 34 0.0005
948 ECZEMA 26 0.0005
949 TREATMENT FAILURE 41 0.0005
950 THERAPEUTIC RESPONSE DECREASED 30 0.0005
951 DYSGEUSIA 36 0.0005
952 DRY EYE 24 0.0005
953 SUICIDAL IDEATION 44 0.0005
954 MYELOSUPPRESSION 17 0.0005
955 BREAST CANCER 42 0.0005
956 ARTHROPATHY 25 0.0004
957 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 90 0.0004
958 NASAL CONGESTION 26 0.0004
959 CRYING 16 0.0004
960 HOT FLUSH 33 0.0004
961 VAGINAL HAEMORRHAGE 19 0.0004
962 THERAPY INTERRUPTED 31 0.0004
963 INJURY 30 0.0004
964 ADVERSE EVENT 39 0.0004
965 ADVERSE DRUG REACTION 38 0.0004
966 FLUSHING 43 0.0004
967 MUSCULOSKELETAL STIFFNESS 37 0.0004
968 DRUG DOSE OMISSION 69 0.0004
969 ANGER 14 0.0004
970 CONVULSION 23 0.0004
971 THERAPEUTIC RESPONSE UNEXPECTED 18 0.0004
972 BLADDER CANCER 23 0.0004
973 SINUSITIS 40 0.0004
974 INFLUENZA LIKE ILLNESS 32 0.0004
975 PRODUCT SUBSTITUTION ISSUE 21 0.0004
976 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 25 0.0004
977 OCULAR HYPERAEMIA 16 0.0003
978 THROAT IRRITATION 15 0.0003
979 SKIN IRRITATION 15 0.0003
980 RHEUMATOID ARTHRITIS 37 0.0003
981 INJECTION SITE SWELLING 23 0.0003
982 PSORIASIS 39 0.0003
983 PROSTATE CANCER 22 0.0003
984 INJECTION SITE ERYTHEMA 32 0.0003
985 ACCIDENTAL EXPOSURE TO PRODUCT 25 0.0002
986 DRUG EFFECT DECREASED 13 0.0002
987 EMOTIONAL DISTRESS 29 0.0002
988 DRUG WITHDRAWAL SYNDROME 21 0.0002
989 INJECTION SITE REACTION 16 0.0002
990 SKIN BURNING SENSATION 16 0.0002
991 NO ADVERSE EVENT 29 0.0002